Adaptive Biotechnologies COO Julie Rubinstein reports sale of $708,557.50 in common shares
ADPT•President and COO Julie Rubinstein sold 23,762 Adaptive Biotechnologies common shares on Nov. 9-10, 2026, for a reported $708,557.50. She also exercised options for 23,762 shares at $12.14 each.
1. Share transactions
Rubinstein sold 23,762 common shares on Nov. 9-10 at reported weighted-average prices ranging from $28.87 to $30.58 per share. She exercised stock options for 23,762 common shares at $12.14 per share. After the transactions, her direct holdings totaled 377,802 common shares, with 35,228 stock options remaining.
